Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults - PubMed (original) (raw)

Randomized Controlled Trial

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Christopher R Martens et al. Nat Commun. 2018.

Abstract

Nicotinamide adenine dinucleotide (NAD+) has emerged as a critical co-substrate for enzymes involved in the beneficial effects of regular calorie restriction on healthspan. As such, the use of NAD+ precursors to augment NAD+ bioavailability has been proposed as a strategy for improving cardiovascular and other physiological functions with aging in humans. Here we provide the evidence in a 2 × 6-week randomized, double-blind, placebo-controlled, crossover clinical trial that chronic supplementation with the NAD+ precursor vitamin, nicotinamide riboside (NR), is well tolerated and effectively stimulates NAD+ metabolism in healthy middle-aged and older adults. Our results also provide initial insight into the effects of chronic NR supplementation on physiological function in humans, and suggest that, in particular, future clinical trials should further assess the potential benefits of NR for reducing blood pressure and arterial stiffness in this group.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1

Fig. 1

Study flow diagram

Fig. 2

Fig. 2

NAD+ metabolome. NAD+and related metabolite concentrations in peripheral blood mononuclear cells increased after oral placebo vs. NR supplementation normalized to total protein content. Data are mean ± SD. * indicates unadjusted P < 0.05 by one-tailed paired _t-_test. N = 21 (Group A = 11; Group B = 10)

Fig. 3

Fig. 3

Blood pressure. Effect of 6 weeks of oral placebo vs. NR supplementation on a systolic (SBP) and b diastolic (DBP) blood pressure, and c pulse pressure (PP) in healthy middle-aged and older adults as a whole N = 24 (Group A = 12; Group B = 12), and overall change from placebo in blood pressure parameters (d−f) in subjects with normal (N = 11) vs. above normal (N = 13) baseline BP. Data are mean ± SD. _P-_values reported in individual bars based on a one-tailed paired _t_-test (panels a−c only) and an adjusted alpha level set at 0.006

Fig. 4

Fig. 4

Arterial function. Effect of 6 weeks of oral placebo vs. NR supplementation on a aortic pulse wave velocity (PWV) as a whole (N = 24; 12 per group), b subgroups of individuals with normal (N = 11) vs. above-normal (N = 13) baseline BP); c carotid artery compliance (CC) and d brachial artery flow-mediated dilation (FMD) in the overall groups (N = 24; 12 per group). Data are mean ± SD. _P_-values reported in individual bars based on one-tailed paired _t_-test (panels a, c, and d only) and an adjusted alpha level set at 0.006

Similar articles

Cited by

References

    1. Mozaffarian D, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133:E38–E360. doi: 10.1161/CIR.0000000000000350. - DOI - PubMed
    1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–146. doi: 10.1161/01.CIR.0000048892.83521.58. - DOI - PubMed
    1. Donato AJ, et al. Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell. 2013;12:772–783. doi: 10.1111/acel.12103. - DOI - PMC - PubMed
    1. Young JB, FAU - Mullen D, Mullen D, FAU - Landsberg L, Landsberg L. Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism. 1978;27:1711–1714. doi: 10.1016/0026-0495(78)90256-1. - DOI - PubMed
    1. Pierce GL, et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008;52:72–79. doi: 10.1161/HYPERTENSIONAHA.108.111427. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources